Literature DB >> 9431347

Inflammatory bowel disease.

M A Roy1.   

Abstract

The vast majority of patients with inflammatory bowel disease experience chronic symptoms punctuated by periodic exacerbations requiring adjustments in medical therapy or surgery. True emergencies are fortunately uncommon but have been associated with high rates of morbidity and mortality. Patients presenting with fulminant colitis, toxic megacolon, or perforation require prompt identification as well as intensive medical therapy and monitoring by physicians and surgeons experienced in the care of such patients. Recent advances in the evaluation and treatment of these complicated patients are reviewed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9431347     DOI: 10.1016/s0039-6109(05)70625-3

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Laparoscopic-assisted vs open colectomy for severe acute colitis in patients with inflammatory bowel disease (IBD): a retrospective study in 42 patients.

Authors:  M S Dunker; W A Bemelman; J F Slors; R A van Hogezand; J Ringers; D J Gouma
Journal:  Surg Endosc       Date:  2000-10       Impact factor: 4.584

2.  Colonic Crohn's disease.

Authors:  Steven Mills; Michael J Stamos
Journal:  Clin Colon Rectal Surg       Date:  2007-11

3.  Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery.

Authors:  Ilaria Russo; Alessandro Luciani; Paola De Cicco; Edoardo Troncone; Carolina Ciacci
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.